Aethlon Medical released FY2025 Q3 earnings on February 12 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -10.0543 (forecast USD -16.2666)

Brief Summary

In its fiscal third-quarter 2025 earnings report, Aethlon Medical posted zero revenue, which was in line with market expectations, alongside a loss per share of -$10.0543, significantly better than the anticipated loss of -$16.2666.

Impact of The News

Analysis of Aethlon Medical’s Q3 2025 Financial Results